EDIT: Editas Medicine Inc
今日EDIT汇率已更改-2.71%。当日,交易品种以低点2.50和高点2.60进行交易。
关注Editas Medicine Inc动态。实时报价将帮助您快速应对市场变化。通过在不同的时间周期之间切换,您可以按分钟、小时、天、周和月监控汇率趋势和动态。使用这些信息来预测市场变化并做出明智的交易决策。
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
EDIT新闻
- Editas: Downgrade "Hold" Reni-Cel Discontinuation SCD/TDT And EDIT-401 Strategic Shift
- EDIT Set to Begin First-in-Human Study in Hypercholesterolemia
- Wells Fargo Upgrades Editas Medicine to Overweight, Raises Price Target to $6
- Editas Medicine获批在澳大利亚启动其针对杂合子家族性高胆固醇血症患者的EDIT-401 I/II期STRIVE临床试验
- Editas Medicine Receives Approval To Initiate Its Phase 1/2 Strive Clinical Trial Of EDIT-401 In Patients With Heterozygous Familial Hypercholesterolemia In Australia
- Beam Therapeutics: Ignore The Anthropic Noise And Focus On Clinical Progress (NASDAQ:BEAM)
- Prime Medicine: A Buy Due To BLA Filing H1 '27 And In Vivo Therapy Development (PRME)
- Crispr Therapeutics: Why AI Giant Anthropic's Discovery Has Rocked Gene Editing (CRSP)
- TriSalus Life Sciences, Lakefront Biotherapeutics, Editas Medicine And Other Big Stocks Moving Higher On Wednesday
- 星期三 TriSalus 生命科学、Lakefront 生物治疗、Editas 医药等大型股票正在上涨
- Guggenheim Upgrades Editas Medicine to Buy, Announces $5 Price Target
- 古根海姆将Editas Medicine评级升至买入,宣布5美元的目标股价
- Gene-Editing Powerhouse And Its Rivals Surge Toward A Breakout
- Editas (EDIT) Up 6.2% Since Last Earnings Report: Can It Continue?
- Editas - Slow Progress Doesn't Mean No Progress For In-Vivo Gene Editor (NASDAQ:EDIT)
- 4 Gene-Editing Biotech Stocks Worth Watching for Long-Term Gains
- Is Editas Medicine (EDIT) Outperforming Other Medical Stocks This Year?
- EDIT Q2 Earnings Beat Estimates, Revenues Rise, Pipeline in Focus
- Editas Medicine (EDIT) Reports Q2 Loss, Beats Revenue Estimates
- Geron (GERN) Reports Q2 Loss, Beats Revenue Estimates
- Why Is Editas (EDIT) Down 12.4% Since Last Earnings Report?
- Editas Medicine: Resetting Pipeline Just To Be Second To Market Again (NASDAQ:EDIT)
EDIT交易应用程序
常见问题解答
EDIT股票今天的价格是多少?
Editas Medicine Inc股票今天的定价为2.51。它在2.50 - 2.60范围内交易,昨天的收盘价为2.58,交易量达到1722。EDIT的实时价格图表显示了这些更新。
Editas Medicine Inc股票是否支付股息?
Editas Medicine Inc目前的价值为2.51。股息政策取决于公司,而投资者也会关注-18.51%和USD。实时查看图表以跟踪EDIT走势。
如何购买EDIT股票?
您可以以2.51的当前价格购买Editas Medicine Inc股票。订单通常设置在2.51或2.81附近,而1722和-3.09%显示市场活动。立即关注EDIT的实时图表更新。
如何投资EDIT股票?
投资Editas Medicine Inc需要考虑年度范围1.66 - 3.94和当前价格2.51。许多人在以2.51或2.81下订单之前,会比较-3.83%和。实时查看EDIT价格图表,了解每日变化。
Editas Medicine Inc股票的最高价格是多少?
在过去一年中,Editas Medicine Inc的最高价格是3.94。在1.66 - 3.94内,该股波动显著,与相比有助于发现阻力位。使用实时图表跟踪Editas Medicine Inc的绩效。
Editas Medicine Inc股票的最低价格是多少?
Editas Medicine Inc(EDIT)的最低价格为1.66。将其与当前的2.51和1.66 - 3.94进行比较,可以发现潜在的长期切入点。观看EDIT在图表上的实时走势以获取更多详细信息。
EDIT股票是什么时候拆分的?
Editas Medicine Inc历史上曾经历过股票拆分。这些变化在公司行动后的、2.58和-18.51%中可见。
- 前一天收盘价
- 2.58
- 开盘价
- 2.59
- 卖价
- 2.51
- 买价
- 2.81
- 最低价
- 2.50
- 最高价
- 2.60
- 交易量
- 1.722 K
- 日变化
- -2.71%
- 月变化
- -3.83%
- 6个月变化
- -15.20%
- 年变化
- -18.51%
- 实际值
- 194 K
- 预测值
- 198 K
- 前值
- 200 K
- 实际值
- 1.728 M
- 预测值
- 1.723 M
- 前值
- 1.703 M
- 实际值
- 预测值
- 0.0%
- 前值
- -0.1%
- 实际值
- 预测值
- 前值
- 1.955%